Search
for
Sort by
Research 31–60 of 1000+
- EFFECT OF THYROID DYSFUNCTION ON BODY MASS INDEX AND HORMONAL IMBALANCE IN WOMEN HAVING POLYCYSTIC OVARIAN SYNDROME
- Guidelines on the use of finasteride in androgenetic alopecia
- Sexuality in premature ovarian insufficiency
- The role of androgens in hormone replacement therapy
- Sexual dysfunction, including hypoactive sexual desire disorder: Diagnosis and treatment recommendations
- Male gonadal function in coeliac disease: 2. Sex hormones.
- Testosterone Pellets in Women: Revisiting Safety and Clinical Outcomes
- Effect of norplant on androgens and sexual function
- Androgen treatment of postmenopausal women
- What is the Rationale for Androgen Therapy for Women?
- Safety and Efficacy Assessment of Red Ginseng Oil (RXGIN) in Men with Lower Urinary Tract Symptoms in a Randomized, Double-Blind, Placebo-Controlled Trial
- The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review
- Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
- PROLACTIN AND HYPERPROLACTINAEMIA IN FEMALE REPRODUCTIVE ENDOCRINOLOGY – AN UPDATE
- The Polycystic Ovary Syndrome Health-Related Quality-of-Life Questionnaire: Confirmatory Factor Analysis
- Plasma Diaphanous Related Formin 1 Levels Are Associated with Altered Glucose Metabolism and Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Case Control Study
- National consensus on the management of patients with hyperandrogenism (2016)
- The North American Menopause Society Recommendations for Clinical Care of Midlife Women
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Androgen replacement therapy in women
- Androgen treatment in women
- Testosterone Therapy in Premenopausal Women
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- FROM PATHOPHYSIOLOGY TO POTENTIAL INTERVENTIONS: INVESTIGATING THE INTRICATE DYNAMICS OF POLYCYSTIC OVARY SYNDROME, AGING, AND FERTILITY
- RETIRED: Managing Menopause Chapter 8 Sexuality and Menopause